Mon - Fri 09:00 - 17:00 +61 3 7016 0801info@aeternahealth.com.au
Preventive Health
Advanced technology
Regenerative medicine technologies
Development and commercialization
Cellular Clinical Research
Innovation for medical practitioners

News

Adding Life to Life
1719205789 AMcpdS Accreditation Badge ID 013446 General Practitioner 1 副本
  We are thrilled to announce that Aeterna Health has achieved CPD accreditation in three crucial fields: General Practice, Physiotherapy, and Osteopathy. This...
1719205268 图片 20240524145528
On May 23rd, 2024, Aeterna Health was honored to participate in the BEYOND EXPO 2024 held in Macau, China. Our Chief Scientific Officer,...
Aeterna Health Services
Aeterna Health was recently invited to attend the Engaging For Impact In Cancer Conference 2022, sponsored by RMIT University. Gathering with leading academics...
shutterstock 1038840406
Aeterna Health collaborates with the Hudson Institute on clinical research Aeterna Health collaborates with the Hudson Institute on clinical research examining the relationship...
covid19
What you need to know about coronavirus (COVID-19) Learn about COVID-19, how it spreads, who is at risk, what to do if you...

Aeterna Health collaborates with the La Trobe University on clinical research

Aeterna Health, based in the biological cell laboratory at La Trobe University, is engaged in cutting-edge research on immune cell therapy.

This research investigates the interactions between immune cells, immunotherapy, and the immune system, and also explores advanced techniques for immune system reconstruction and related mechanisms.

The TGA registration number for this study is

CT-2021-CTN-03826-1.

Recent Papers

111719205789 AMcpdS Accreditation Badge ID 013446 General Practitioner 1 副本
Celebrating Aeterna Health’s Achievements in CPD Accreditation
24 June 2024
111719205268 图片 20240524145528
Advancing Immunotherapy: Aeterna Health at BEYOND EXPO 2024
24 June 2024

Scientific Excellence

Aeterna Health’s scientific excellence is supported by world-class experts in the field as well as cutting-edge cell biotechnology built on the platforms of top universities, hospitals and research institutes in Germany, Australia, China and the United States.